Thus, the cleavage of a growth factor (NRG1 type III) by MMP-2 and the subsequent phosphorylation of the ErbB transmembrane tyrosine kinase receptor could explain the late MAPK phosphorylation observed in Schwannoma cells after UTP treatment. Here, EGFR is linked to schwannoma.